Bacteremia in Peruvian Cancer Patients with 28-Day Mortality Factors, 2020-2024

Peruvian cancer patients at a referral center in Lima were studied for bacteremia outcomes. The dataset contains results from a retrospective analysis of 293 patients hospitalized between July 2020 and June 2024, authored by Yosué Vera. It reports a 28-day all-cause mortality rate of 32.1% and identifies factors like sepsis, comorbidities, and specific pathogens associated with increased mortality.

Use Cases

• Modeling 28-day mortality risk based on patient comorbidities and infection severity mentioned in the description
• Analyzing the prevalence and impact of antimicrobial resistance (ESBL, carbapenem-resistant) in a cancer patient cohort
• Studying the distribution of bacterial isolates, such as the predominance of Gram-negative bacteria like Escherichia coli
• Investigating associations between specific bacteremia characteristics (e.g., CoNS, primary source) and patient outcomes

Strengths

• Includes 293 patient records with detailed demographic and clinical characteristics (e.g., 65.4 mean age, 53.9% female, 84.3% solid tumors)
• Provides specific mortality rate (32.1%) and statistical associations (e.g., RR values) from multivariable regression analysis
• Covers a defined 4-year time range (July 2020 to June 2024) at a single referral center, allowing for temporal consistency

Limitations

• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment for certain analytical tasks
• Data reflects a single-center study in Lima, Peru, which may limit generalizability to other geographic or healthcare settings

Provenance

Source

figshare, authored by Yosué Vera

Collection Method

Retrospective analysis of first bacteremia episodes in hospitalized adult cancer patients

Time Range

July 2020 to June 2024

Freshness

Last updated 2026-05-22 17:43:16; freshness should be verified

Geography

Lima, Peru (a single referral cancer center)